Literature DB >> 24668940

Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs.

Hidetoshi Yamada1, Eriko Oshiro, Sayaka Kikuchi, Mayuka Hakozaki, Hideyuki Takahashi, Ken-Ichi Kimura.   

Abstract

PPARs regulate the expression of genes for energy metabolism in a ligand-dependent manner. PPARs can influence fatty acid oxidation, the level of circulating triglycerides, glucose uptake and insulin sensitivity. Here, we demonstrate that 5-hydroxyeicosapentaenoic acid (HEPE), 8-HEPE, 9-HEPE, 12-HEPE and 18-HEPE (hydroxylation products of EPA) obtained from methanol extracts of Pacific krill (Euphausia pacifica) can act as PPAR ligands. Two of these products, 8-HEPE and 9-HEPE, enhanced the transcription levels of GAL4-PPARs to a significantly greater extent than 5-HEPE, 12-HEPE, 18-HEPE, EPA, and EPA ethyl-ester. 8-HEPE also activated significantly higher transcription of GAL4-PPARα, GAL4-PPARγ, and GAL4-PPARδ than EPA at concentrations greater than 4, 64, and 64 μM, respectively. We also demonstrated that 8-HEPE increased the expression levels of genes regulated by PPARs in FaO, 3T3-F442A, and C2C12 cells. Furthermore, 8-HEPE enhanced adipogenesis and glucose uptake. By contrast, at the same concentrations, EPA showed weak or little effect, indicating that 8-HEPE was the more potent inducer of physiological effects.

Entities:  

Keywords:  adipogenesis; fatty acid oxidation; glucose uptake; peroxisome proliferator-acitivated receptor

Mesh:

Substances:

Year:  2014        PMID: 24668940      PMCID: PMC3995467          DOI: 10.1194/jlr.M047514

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

1.  Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.

Authors:  M Guerre-Millo; P Gervois; E Raspé; L Madsen; P Poulain; B Derudas; J M Herbert; D A Winegar; T M Willson; J C Fruchart; R K Berge; B Staels
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

2.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

Authors:  N Kubota; Y Terauchi; H Miki; H Tamemoto; T Yamauchi; K Komeda; S Satoh; R Nakano; C Ishii; T Sugiyama; K Eto; Y Tsubamoto; A Okuno; K Murakami; H Sekihara; G Hasegawa; M Naito; Y Toyoshima; S Tanaka; K Shiota; T Kitamura; T Fujita; O Ezaki; S Aizawa; T Kadowaki
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

3.  Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

Authors:  K Yu; W Bayona; C B Kallen; H P Harding; C P Ravera; G McMahon; M Brown; M A Lazar
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

4.  Unbound free fatty acid levels in human serum.

Authors:  G V Richieri; A M Kleinfeld
Journal:  J Lipid Res       Date:  1995-02       Impact factor: 5.922

5.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

Authors:  B M Forman; P Tontonoz; J Chen; R P Brun; B M Spiegelman; R M Evans
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

6.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

7.  Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors.

Authors:  E Z Amri; F Bonino; G Ailhaud; N A Abumrad; P A Grimaldi
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

Review 8.  Fenofibrate: treatment of hyperlipidemia and beyond.

Authors:  Robert S Rosenson
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-11

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models.

Authors:  Kensuke Tomio; Kei Kawana; Ayumi Taguchi; Yosuke Isobe; Ryo Iwamoto; Aki Yamashita; Satoko Kojima; Mayuyo Mori; Takeshi Nagamatsu; Takahide Arimoto; Katsutoshi Oda; Yutaka Osuga; Yuji Taketani; Jing X Kang; Hiroyuki Arai; Makoto Arita; Shiro Kozuma; Tomoyuki Fujii
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more
  16 in total

1.  Dietary Docosahexaenoic Acid and trans-10, cis-12-Conjugated Linoleic Acid Differentially Alter Oxylipin Profiles in Mouse Periuterine Adipose Tissue.

Authors:  Yuriko Adkins; Benjamin J Belda; Theresa L Pedersen; Dawn M Fedor; Bruce E Mackey; John W Newman; Darshan S Kelley
Journal:  Lipids       Date:  2017-04-13       Impact factor: 1.880

2.  Distinct differences in serum eicosanoids in healthy, enteritis and colorectal cancer individuals.

Authors:  Junjie Zhang; Qingjin Yang; Jian Li; Yu Zhong; Lijian Zhang; Qionglin Huang; Bin Chen; Mingming Mo; Sensen Shen; Qisheng Zhong; Huwei Liu; Chun Cai
Journal:  Metabolomics       Date:  2017-11-27       Impact factor: 4.290

Review 3.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

Review 4.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

5.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

6.  12-Hydroxyeicosapentaenoic acid inhibits foam cell formation and ameliorates high-fat diet-induced pathology of atherosclerosis in mice.

Authors:  Takahiro Nagatake; Yuki Shibata; Sakiko Morimoto; Eri Node; Kento Sawane; So-Ichiro Hirata; Jun Adachi; Yuichi Abe; Junko Isoyama; Azusa Saika; Koji Hosomi; Takeshi Tomonaga; Jun Kunisawa
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

7.  8-Hydroxyeicosapentaenoic Acid Decreases Plasma and Hepatic Triglycerides via Activation of Peroxisome Proliferator-Activated Receptor Alpha in High-Fat Diet-Induced Obese Mice.

Authors:  Hidetoshi Yamada; Sayaka Kikuchi; Mayuka Hakozaki; Kaori Motodate; Nozomi Nagahora; Masamichi Hirose
Journal:  J Lipids       Date:  2016-04-28

8.  Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.

Authors:  Roberto Rodriguez-Echevarria; Jose Macias-Barragan; Marcela Parra-Vargas; Judith Rebeca Davila-Rodriguez; Eduardo Amezcua-Galvez; Juan Armendariz-Borunda
Journal:  World J Gastroenterol       Date:  2018-01-28       Impact factor: 5.742

9.  Nrf2 Activation by 5-lipoxygenase Metabolites in Human Umbilical Vascular Endothelial Cells.

Authors:  Nozomi Nagahora; Hidetoshi Yamada; Sayaka Kikuchi; Mayuka Hakozaki; Akira Yano
Journal:  Nutrients       Date:  2017-09-11       Impact factor: 5.717

10.  Lipids, fatty acids and hydroxy-fatty acids of Euphausia pacifica.

Authors:  Hidetoshi Yamada; Yuya Yamazaki; Seiji Koike; Mayuka Hakozaki; Nozomi Nagahora; Sayaka Yuki; Akira Yano; Koichiro Tsurumi; Takuji Okumura
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.